• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer

    2018-12-07 06:21:42MingGaoMinghuaGeQinghaiJiRuochuanChengHankuiLuHaixiaGuanWeiCuiLiGaoZairongGaoLinGuo0ZhumingGuoTaoHuangXiaomingHuangYansongLinQinjiangLiuXinNiJianwuQinLiRenZhongyanShanHuiSunXudongWangZhengangXu0YangYuBinZhang
    Cancer Biology & Medicine 2018年4期

    Ming Gao, Minghua Ge, Qinghai Ji, Ruochuan Cheng, Hankui Lu, Haixia Guan, Wei Cui, Li Gao, Zairong Gao, Lin Guo0, Zhuming Guo, Tao Huang, Xiaoming Huang, Yansong Lin, Qinjiang Liu, Xin Ni, Jianwu Qin, Li Ren, Zhongyan Shan, Hui Sun, Xudong Wang, Zhengang Xu0, Yang Yu, Bin Zhang, Daiwei Zhao, Ying Zheng, Jingqiang Zhu, Xiangqian Zheng, Chinese Association of Thyroid Oncology (CATO),China Anti-Cancer Association

    1Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer,Tianjin 300060, China; 2Department of Head and Neck, Zhejiang Cancer Hospital, Hangzhou 310022, China; 3Department of Head and Neck Tumor, Fudan University Shanghai Cancer Center, Shanghai 200433, China; 4Department of General Surgery,First Affiliated Hospital of Kunming Medical University, Kunming 650032, China; 5Department of Nuclear Medicine, The Sixth Affiliated Hospital of Shanghai Jiao Tong University, Shanghai 200025, China; 6Department of Endocrinology, The First Hospital of China Medical University, Shenyang 110001, China; 7Department of Clinical Laboratory, Cancer Hospital Chinese Academy of Medical Science, Beijing 100021, China; 8Department of Head and Neck, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China; 9Department of Nuclear Medicine, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China; 10Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai 200433, China; 11Sun Yat-sen University Cancer Center, Guangzhou 510060,China; 12Department of Thyroid and Breast, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan 430030, China; 13Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China; 14Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing 100730, China; 15Department of Head and Neck, Gansu Provincial Cancer Hospital, Lanzhou 730050, China; 16Department of Head and Neck, Beijing Children’s Hospital, Capital Medical University, Beijing 100045, China; 17Department of Thyroid, Head and Neck, Henan Cancer Hospital, Zhengzhou 450008, China; 18Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China; 19Department of Thyroid, Sino Japanese Union Hospital of Jilin University, Changchun 130033, China; 20Department of Head and Neck, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China; 21Department of Head and Neck, Peking Union Medical College Hospital, Beijing 100730, China; 22Department of General Surgery, The Second Affiliated Hospital of Guizhou Medical University, Kaili 556099, China; 23Department of Head and Neck, Jilin Tumor Hospital, Changchun 130012, China;24Department of Thyroid and Breast, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610047, China

    In recent years, the clinical incidence of thyroid cancer has been increasing year by year, and its risk assessment and clinical management methods have also been accordingly modified and constantly improved. There are great differences between the clinical diagnostic and therapeutic modes and disease management of thyroid cancer employed by various medical institutions in China, particularly with regard to the clinical application of serum marker of thyroid cancer. To this end, the China Anti-Cancer Association Thyroid Cancer Specialized Committee Chinese Association of Thyroid Oncology organized this compilation of Expert Consensus on Clinical Application of Serum Marker of Thyroid Cancer to help and impel relevant clinical institutions and professionals to standardize clinical diagnosis, treatment, and long-term management of thyroid cancer, and to properly utilize the serum marker for scientific auxiliary clinical diagnosis and assessment of thyroid cancer before and after operation. A total of 14 recommendations have been put forward in this consensus for measuring the levels of serum marker of thyroid cancer. In view of the limited references,especially regarding the perspective data currently available at home and abroad, omissions are inevitable. Moreover, we also hope that the professionals can give more valuable suggestions for regular revision in the future (see categories of recommendations in Table 1 and detailed recommendations in Table 2).

    Criteria for setting of recommendation grade

    The recommendations on the clinical application of serum marker of thyroid cancer in Expert Consensus are based on evidence-based medicine and expert opinions, and the categories of recommendations are as follows:

    For the clinical laboratory test of serum marker of thyroid cancer, immunological test methods are more commonly used at present, including methods used for estimating levels of thyroglobulin (Tg) and calcitonin (Ctn). Ctn is the serum marker of medullary thyroid carcinoma (MTC), and Tg can be used as the serum marker of differentiated thyroid carcinoma (DTC). Anti-thyroglobulin antibody (TgAb) is the autoimmune antibody generated against Tg, and the existence of serum TgAb and the quantitative changes associated with it have a direct impact on the measurement of the serum Tg value. The carcinoembryonic antigen (CEA)is associated with diagnosis and clinical progress in some patients with MTC, and it can be used as a serum marker for MTC along with Ctn.

    DTC

    Preoperative serological test and assessment of DTC

    Recommendation 1: For all patients with thyroid cancer considered for operative treatment, thyroid function including serum thyroid-stimulating hormone level shall be tested before the operation (grade of recommendation: A).For all patients with thyroid tumor considered for operative treatment, thyroid function, including the level of thyroidstimulating hormone (TSH), shall be tested. Assessing thyroid function can help surgeons and anesthetists to judge the safety in operative treatment of patients, and preoperative thyroid function shall be routinely tested. For patients with abnormal thyroid function, medical treatment shall be appropriately performed to ensure that the thyroid function is within the acceptable range for surgery. A previous study1showed that the incidence of malignant nodules in patients with thyroid tumor and TSH level below the normal range is lower than that in patients with normal or elevated TSH level. Therefore, to some extent, TSH level serves as a meaningful reference for malignant tumor assessment, and it is routinely recommended to measure it.

    Recommendation 2: It is not recommended to use Tg for diagnosis and differentiation of benign and malignant thyroid tumor (grade of recommendation: E).

    Tg is the specific protein generated by thyroid and secreted by the thyroid follicular epithelial cells. Many thyroid diseases can cause the elevation of serum Tg level, including DTC, goiter, thyroiditis, thyroid injury, hyperthyroidism, etc.At present, the detection reagents are unable to distinguish“tumor-induced” Tg from the “normal tissue-derived.”Therefore, serum Tg cannot be used to distinguish the difference between benign and malignant thyroid tumor2-4.

    Recommendation 3: Tg and TgAb levels can be tested routinely before operation of thyroid cancer, and it is recommended to simultaneously test both for assessment of the initial clinical state and serological index baseline(grade of recommendation: A).

    High level of preoperative serum Tg suggests its better sensitivity in postoperative monitoring, and preoperative measurements of Tg and TgAb baseline values can theoretically assess the reliability of Tg and TgAb tests in postoperative assessment. Trumboli et al.5conducted a largesample analysis on serum Tg levels in patients with thyroid nodules and indicated that the preoperative serum Tg level can be taken as an index for assessment of the initial clinical state of thyroid cancer and should be routinely tested before operation. The expert group recommends that a simultaneous test of Tg and TgAb levels should be conducted for an assessment of the initial clinical state and serological index baseline.

    Table 1 Categories of recommendations

    Table 2 Recommendations

    Marker measurements in washout fluid from preoperative fine needle aspiration (FNA) of lymph nodes of DTC

    Recommendation 4: If suspected metastatic lymph nodes are observed in preoperative neck examination of DTC,measurement of Tg level in FNA washout fluid can be optionally used as an auxiliary method to evaluate metastatic lymph nodes (grade of recommendation: B).

    Cervical lymph node metastasis is commonly observed in DTC. Ultrasonography and CT are commonly used to assess the cervical lymph node metastasis, but they have limitations.For a few suspicious metastatic lymph nodes undetermined in imaging examination, ultrasound-guided FNA pathology diagnosis and/or Tg measurement in washout fluid can be used as auxiliary diagnostic methods6-7. If the evidence for assessment of lymph node cytology is insufficient or if the cytological findings are not in consensus with the imaging findings, measurement of Tg values in washout fluid must be performed. A study showed that the sensitivity, specificity,and accuracy of FNA combined with Tg measurement in washout fluid were 87.0%, 100%, and 92.2%, respectively8-10.Therefore, the measurement of Tg value in FNA washout fluid can be used as an auxiliary method to determine the lymphatic metastasis. However, a minority of false-positive results may occur, particularly during evaluation of central compartment lymph nodes in the presence of thyroid11-12.

    As normal saline does not contain Tg and is the most commonly used solution in clinical practice, puncture needles must be washed with normal saline and dilute into washout fluid. A study showed that the FNA-Tg levels in serum separation tubes (pro-coagulation tubes) and heparin anti-coagulation tubes significantly decreased compared with those in common serum tubes. Therefore, a common serum tube is recommended to be used in the collection of FNA washout fluid. The requirements for lymph node FNA-Tg detection reagents are in accordance with those for serum Tg detection reagent. Meanwhile, reagents with high sensitivity shall be used to ensure that the little amount of Tg in washout fluid can be detected.

    Serological test in DTC postoperative assessment and follow-up

    Recommendation 5: Tg and TgAb should be routinely tested after total thyroidectomy of DTC, using the same manufacturer’s reagents, and should be evaluated serially over time at various time points during follow-up for continuous assessment of postoperative recurrence risk and treatment response (grade of recommendation: A).

    Serum Tg can be a tumor maker of DTC after total thyroidectomy (particularly after the treatment with radioactive iodine ablation), and its level has a positive correlation with tumor burden in DTC patients, which can be used as a clinical marker for assessment of tumor recurrence and metastasis. However, as the serological Tg test is affected by TgAb level in the body, clinical studies in different populations and with test assays showed that positive TgAb can be found in 25%–30% of DTC patients in the first diagnosis13. To accurately evaluate, TgAb shall be routinely measured along with serum Tg. The fist measurement shall be generally conducted within 3–4 weeks after operation or ablation, and the expert group recommends to continuously measure Tg and TgAb for assessment of postoperative recurrence risk and treatment response based on the trend in changing values.

    DTC treatment responses are as follows: 1) excellent response: no disease-related evidence, including no clinical and biochemical indexes or structural-related evidence; 2)biochemical incomplete response: continuous elevation of serum Tg or TgAb, without evidence of local lesion; 3)structural incomplete response: continuous or new local/distant metastasis; 4) indeterminate response: no specific biochemical or structural abnormality or unable to confirm whether the lesion is benign or malignant. Patients may have stable or decreased TgAb value, without relevant evidence to prove the existence of the lesion.

    Recurrence risk of DTC and disease-related mortality can change at any time under the impact of clinical disease course and treatment response. Therefore, the initial recurrence risk stratification cannot remain stubbornly unchanged and shall be continuously amended during follow-up14. See Tables 3 and 4 for the summary for dynamic risk stratification with total thyroidectomy15.

    Recommendation 6: Unstimulated Tg and TgAb test results can be taken as the baseline values for treatment response assessment after thyroid lobectomy of DTC, and further examination shall be performed to confirm whether there is recurrence and metastasis if Tg level continuously elevates (grade of recommendation: B).

    After thyroid lobectomy of DTC, accurately assessing the cutoff value of serum Tg level for treatment response has no clear definition. However, the results of unstimulated serum Tg test performed 1 month after operation can be considered as the baseline Tg value for long-term follow-up anddynamic risk assessment of patients according to the present available data16,17. For patients with continuous elevation in unstimulated serum Tg level, clinically visible lesions mostly exist, and further imaging examination is recommended to confirm lesions18. A stable or declined unstimulated serum Tg value is a good predictive index for “disease-free status”with a predicating accuracy up to above 80%19. See Table 5 for the dynamic risk stratification with thyroid lobectomy of DTC15.

    Table 3 Dynamic risk stratification in DTC patients with total thyroidectomy and radioiodine remnant ablation15

    Table 4 Dynamic risk stratification in DTC patients with total thyroidectomy only15

    Along with the update on Tg detection reagents20, the detection sensitivity, and sensitivity and precision in low concentration range of highly sensitive Tg (functional sensitivity less than 0.1 ng/mL) have greatly improved. With the emergence of highly sensitive Tg test, the “TSH-stimulated Tg level” might no longer be used for routine assessment of “excellent response” in DTC patients who underwent total thyroidectomy. Suppressed Tg level test is effective in monitoring the postoperative remission of diseases16.

    Recommendation 7: It is recommended to frequently measure serum Tg and TgAb after surgery and assess the dynamic risk stratification to guide the adjustment of DTC follow-up scheme and treatment decisions (grade of recommendation: A).

    After total thyroidectomy, Tg level in most patients with DTC reaches the lowest concentration 1 month after operation20-21. As the postoperative early assessment indexes and important predictive factors, serum Tg and TgAb values can be used to guide the selection of clinical treatment regimen. The major guidance is listed below:

    1) Excellent response: The follow-up intensity and frequency shall be decreased, and the goal of TSH suppressive treatment shall be broadened (lower limit of normal: 2.0 mU/L). Definition of low-risk patients with treatment of total thyroidectomy is to have a postoperative stimulated or suppressed Tg of less than 1 ng/mL, whose prognosis is reliable. Intermediate-risk patients are to have postoperative Tg of less than 1 ng/mL, whose prognosis is reliable with a possibility of micrometastasis. For low-risk and intermediaterisk patients without radioactive iodine treatment,postoperative unstimulated Tg of less than 1 ng/mL indicates favorable treatment response, and the recurrence risk is less than 1%22.

    Table 5 Dynamic risk stratification in DTC patients with thyroid lobectomy only15

    2) Biochemical incomplete response: If Tg value is stable or gradually declining, most patients can be continuously observed on the premise of constant TSH suppressive treatment (lower limit of normal: 0.1 mU/L), and it is not recommended to immediately perform exploratory/preventive operation or radioactive iodine treatment. An elevated Tg or TgAb level is associated with risk for recurrence; because of this, the follow-up frequency might increase, other examinations might be conducted, or other possible treatments might be given. After total thyroidectomy, suppressed or stimulated Tg of 5–10 ng/mL23-26indicates a higher probability of positive imaging on radioactive iodine scan and confirmation of local or distant metastasis. If postoperative Tg is more than 10 ng/mL, other assessments and treatments are probably required. However, Tg may also be very low or undetectable once the tumor becomes undifferentiated or dedifferentiated.

    3) Structural incomplete response: Imaging examination shows that the diseases persistently exist or recur with Tg of more than 10–30 ng/mL after total thyroidectomy, which mostly occurs in patients with failed initial ablation who have local or distant metastasis. Incomplete structure response can cause an increase in mortality27-28. Therefore,multidisciplinary diagnosis and treatment shall be recommended.

    4) Indeterminate response: The goal of TSH suppressive treatment is slightly broadened (lower limit of normal: 1.0 mU/L), and treatment response classification can be reassessed based on the results of imaging examinations and serum Tg/TgAb tests. The initial examination frequency of imaging and serum Tg/TgAb is 1–2 times per year, and the interval can be appropriately prolonged if the condition is stable.

    Recommendation 8: For DTC patients with positive TgAb, postoperative disease states shall be continuously assessed by measuring the variation tendency of serum TgAb levels (grade of recommendation: C).

    Positive TgAb on immunological detection usually means that serum TgAb value is greater than the upper limit of normal reference range of population. However, for postoperative patients with DTC, some scholars think that it is more appropriate to select the lower limit of detection of TgAb as the positive cutoff value of interfering TgAb29-30. For DTC patients who are TgAb positive preoperatively, TgAb value must be monitored during follow-up. As a surrogate indicator, the trend of TgAb is more important than the numerical value. Decreasing serum TgAb level indicates that the disease remits. Conversely, disease recurrence shall be suspected with a continuous increase in serum TgAb levels.Patients with stable serum TgAb shall be diagnosed as indetermination. For follow-up recommendations on DTC patients with positive TgAb after total thyroidectomy, see Figure 130.

    MTC

    Postoperative serological test and assessment of MTC

    Recommendation 9: For patients suspected of malignant thyroid tumor, serum Ctn shall be routinely tested before operation to identify and screen for MTC. For patients with elevated Ctn or considered for MTC, CEA shall also be tested (grade of recommendation: B).

    A series of prospective non-randomized studies have assessed the utility of Ctn and proved that routine serum Ctn screening can discover early C-cell hyperplasia and MTC, so as to improve the detectable rate and overall survival rate of MTC31-35. The American Thyroid Association maintains a neutral attitude to Ctn screening28but still accepts that Ctn screening is of significant value in some patient subgroups.The consensus recommends that preoperative Ctn test should be routinely performed on patients suspected of having malignant thyroid tumor.

    Meanwhile, the expert group suggests that basal values of serum Ctn and CEA should be simultaneously tested if MTC is considered clinically. The serum Ctn value in a few MTC patients may be in normal range, and significant elevation in serum CEA but relative reduction in Ctn may occur in some patients with advanced MTC; some scholars think that patients with poorly differentiated MTC may either have normal serum Ctn and CEA levels or experience a simultaneous decline in serum Ctn and CEA levels36.Therefore, for judgment and assessment of MTC, clinicians should fully analyze the clinical and pathological results in addition to serum Ctn and CEA as reference.

    Recommendation 10: Elevated serum Ctn value can reflect tumor burden in patients with MTC and can be taken as a strong evidence to guide clinical assessment of MTC (grade of recommendation: A).

    Figure 1 Treatment and follow-up flow chart of patients with differentiated thyroid cancer who have positive TgAb WBS: whole body scintiscanning; LT4: levothyroxine; TSH: thyroid stimulating hormone; FT3: free triiodothyronine; FT4: free thyroxine; TgAb: antithyroglobulin antibody; Tg: thyroglobulin; dxWBS: whole body imaging of diagnostic radioactive iodine; PET/CT: positron emission tomography/computed X-ray tomography.

    MTC is characterized by high malignancy, commonly with lymph node metastasis and distant metastasis. Primary and metastatic tumor burden of MTC co-determine and is positively correlated with serum Ctn level. Clinicians can perform a clinical assessment of MTC based on the level of serum Ctn. A study showed that the risk of lymph node metastasis increased when serum Ctn value is more than 20 pg/mL, and the possibility of distant metastasis increased when serum Ctn value is more than 500 pg/mL37. For patients with preoperative serum Ctn value less than 10 pg/mL, “biochemical cure” can be achieved after treatment with complete lymphadenectomy, and postoperative 10-year survival rate is 97.7%38.

    Recommendation 11: Patients diagnosed with MTC shall be mainly treated with total thyroidectomy, and cervical lymph node metastasis and extent of dissection shall be preliminarily evaluated using imaging studies and serum Ctn value (grade of recommendation: B).

    The incidence of lymph node metastasis in MTC patients is high, about 70%–90%, and the lymph node metastasis’behavior is associated with the size and location of primary tumor39,40. Necessary lymph node dissection is required during initial thyroidectomy, and comprehensive assessment shall be conducted on the probability of cervical lymph node metastasis based on the location and size of primary MTC lesion and serum Ctn values. Imaging studies are routine methods employed to assess whether the lymph nodes have metastasis, and preoperative serum Ctn values can also effectively assist in determining the extent of lymph node metastasis. Previous studies showed41,42that it is generally indicated that suspicious lymph nodes had metastasized to the ipsilateral central zone and ipsilateral lateral neck zone,contralateral central zone, and contralateral lateral neck zone and superior mediastinum zone when the serum Ctn values are more than 50, 200, and 500 pg/mL, respectively.

    Recommendation 12: For carriers with hereditary MTC(HMTC) family mutation gene, serum Ctn can be monitored regularly from infancy, which helps discover the changes in disease status early and determine whether operative treatment shall be performed discretionarily according to the patient’s condition (grade of recommendation: B).

    At present, it is recommended in all guidelines at home and abroad that the carriers with HMTC family mutation genes should undergo total thyroidectomy. Due to limited knowledge, most of patients’ family members in China refuse to undergo preventive surgery, while the clinicians shall fully inform them of the serious condition, closely monitor with imaging, and follow up the changes in Ctn.

    In principle, for patients with asymptomatic multiple endocrine neoplasia 2A and familial MTC above 5 years old,and patients with asymptomatic multiple endocrine neoplasia 2B above 1 year old, thorough operative treatment shall be carried out if basal serum Ctn value is more than 40 pg/mL. For adolescent HMTC patients with RET mutation genes and serum Ctn less than 30 pg/mL, preventive thyroidectomy shall be carried out. For patients with serum Ctn value higher than threshold value (10 pg/mL), close follow-up will be the best choice, and preventive thyroidectomy can also be considered43-44. It must be carefully decided whether young infants should undergo surgery or not because they can have elevated serum calcitonin levels and yet still normal for their age group45.

    Intraoperative serological test in MTC

    Recommendation 13: For patients with MTC, it is not recommended to test serum Ctn and CEA during operation to assess the thoroughness of excision (grade of recommendation: F).

    Ctn and parathyroid hormone (PTH) co-participate in the regulation of calcium in the body and maintain stability of calcium metabolism. The half-life of Ctn is more than 1 h,mainly undergoing degradation and excretion from the kidney. However, the half-life of its precursor serum procalcitonin in human body is about 20–24 hours with good stability, continuously forming calcitonin. For patients with high level of preoperative Ctn, the intraoperative Ctn value after tumor resection cannot immediately reflect the thoroughness of operative excision. Similarly, serum CEA is mainly eliminated by Kupffer cells and liver cells with a halflife of 1–7 days. However, depending on liver function, the half-life of serum CEA is prolonged in cholestasis and hepatocellular diseases. Therefore, it is not recommended to routinely test serum Ctn and CEA levels after tumor resection during operation.

    Serology-assisted postoperative management of MTC

    Recommendation 14: Ctn and CEA levels can be considered as important monitoring indexes of postoperative management and prognostic prediction of MTC (grade of recommendation: A).

    Postoperative serum Ctn test can be used to assess the effect of operative treatment in MTC patients, and the normalization of postoperative serum Ctn usually indicates favorable outcome. A previous study showed that serum Ctn value would be even lower than the lower limit of detection after total resection of thyroid tissues46. In view of half-life of Ctn, regarding its metabolism and other factors, it is generally suggested that the optimal time for test of postoperative Ctn minimum value be 3 months after the operation47. However, considering the different tumor burden in various patients, the test time of postoperative serum Ctn and CEA can be 1 week, 1 month, 3 months, and half a year. Regular postoperative re-examination shall be carried out if test values are less than the lower limit of detection or the normal reference range. Initial reexamination period is half a year and can be gradually prolonged to once per year if the condition is stable.

    A study of postoperative long-term observation and follow-up of MTC demonstrated that48the 3-year and 5-year survival rates were 94% and 90%, respectively, if postoperative serum Ctn value was less than 10 pg/mL.Moreover, the 3-year and 5-year survival rates were reduced to 78% and 61%, respectively, if postoperative serum Ctn value was more than 10 pg/mL. If patients exhibit abnormal postoperative basal serum Ctn values after total thyroidectomy, this might indicate the presence of residual lymph nodes or lesions, or that recurrence risk may exist,even if serum Ctn value is less than 150 pg/mL. Therefore,the expert group recommends that neck ultrasound examination shall be performed if postoperative serum Ctn level increases but is less than 150 pg/mL, and Ctn, CEA, and neck ultrasound shall be repeated semiannually for monitoring if test results are negative. If postoperative serum Ctn value is more than 150 pg/mL, neck ultrasound, chest and abdomen CT/MRI, and whole body bone examination must be carried out, and PET/CT examination should be performed when necessary, in order to discover the lesions early.

    Prospect

    Continuous exploration of new methods and new markers for laboratory diagnosis of thyroid cancer: We hope that more molecular makers are used for diagnosis, prognosis assessment, and confirmation of therapeutic targets.

    How to use Tg to assess the treatment response in patients without total thyroidectomy: For patients without total thyroidectomy, serum Tg level is greatly affected and assessment of treatment response cannot entirely rely on it,and new markers or new methods might be used for followup in patients who did not undergo total thyroidectomy.

    Exploration of serum Ctn value in evaluating efficacy of targeted drug treatment of MTC: Serum Ctn levels in MTC patients can greatly reduce after receiving some drug therapies, while those declines have no significant correlation with the changes in tumor size and regression; hence, further studies are needed to verify the feasibility of using serum Ctn as a reliable index for drug effect assessment.

    Exploration of optimum clinical cutoff value of serum markers of thyroid cancer to achieve the optimal clinical specificity and sensitivity: Along with the continuous development of test methodology, the accuracy of reagents constantly improves, and more studies are needed to find the optimal cutoff value and apply that to clinical practice in future, so as to enhance the predictive value in the assessment of tumor stage and tumor recurrence.

    Acknowledgements

    This article was published originally in Chinese Journal of Clinical Oncology 2017; 48: 7-13 (in Chinese).

    Conflict of interest statement

    No potential conflicts of interest are disclosed.

    亚洲一区高清亚洲精品| 欧美色视频一区免费| 嫩草影院精品99| 19禁男女啪啪无遮挡网站| 国产成人福利小说| 中文字幕熟女人妻在线| 一个人观看的视频www高清免费观看 | 狠狠狠狠99中文字幕| 给我免费播放毛片高清在线观看| 国产久久久一区二区三区| 久久国产乱子伦精品免费另类| 国产午夜精品久久久久久| 天天躁日日操中文字幕| 欧美一级毛片孕妇| 国产熟女xx| 国产高清视频在线播放一区| 欧美黑人欧美精品刺激| 麻豆av在线久日| 欧美成人免费av一区二区三区| 国产精品野战在线观看| 久久国产精品人妻蜜桃| 久久久久久大精品| 淫秽高清视频在线观看| 一二三四社区在线视频社区8| 日韩欧美三级三区| 国产一区二区激情短视频| 免费看美女性在线毛片视频| 男女之事视频高清在线观看| 久久亚洲真实| 18禁美女被吸乳视频| 亚洲aⅴ乱码一区二区在线播放| 禁无遮挡网站| 99久久国产精品久久久| 99热6这里只有精品| 成人鲁丝片一二三区免费| 国产人伦9x9x在线观看| 看黄色毛片网站| 亚洲成人久久性| 亚洲精品色激情综合| 日韩高清综合在线| 国产又黄又爽又无遮挡在线| 欧美日韩综合久久久久久 | 一本久久中文字幕| 脱女人内裤的视频| 99国产极品粉嫩在线观看| 成年女人永久免费观看视频| 精品熟女少妇八av免费久了| 亚洲精品456在线播放app | 欧美日韩综合久久久久久 | 12—13女人毛片做爰片一| 99re在线观看精品视频| 国产一区二区在线观看日韩 | xxx96com| 丰满人妻熟妇乱又伦精品不卡| 欧美最黄视频在线播放免费| 免费无遮挡裸体视频| 国产精品综合久久久久久久免费| 一级a爱片免费观看的视频| 精品乱码久久久久久99久播| or卡值多少钱| 亚洲国产欧美一区二区综合| 亚洲欧美日韩高清专用| 久久久久九九精品影院| 一级作爱视频免费观看| 色视频www国产| 丰满人妻熟妇乱又伦精品不卡| 精品国内亚洲2022精品成人| 香蕉久久夜色| 熟女电影av网| 日韩人妻高清精品专区| 国产成人系列免费观看| 国产一区二区在线av高清观看| 免费观看的影片在线观看| 黑人欧美特级aaaaaa片| 成人av一区二区三区在线看| 偷拍熟女少妇极品色| 男人和女人高潮做爰伦理| 一进一出抽搐动态| 99热这里只有精品一区 | 日韩欧美在线乱码| www日本在线高清视频| av女优亚洲男人天堂 | 日本黄大片高清| 日韩欧美精品v在线| 1024香蕉在线观看| 久久久久久大精品| 亚洲国产欧美一区二区综合| 成人鲁丝片一二三区免费| 国产激情偷乱视频一区二区| 在线十欧美十亚洲十日本专区| 精品人妻1区二区| 亚洲最大成人中文| 一进一出抽搐gif免费好疼| 一级a爱片免费观看的视频| 变态另类丝袜制服| 国产精品女同一区二区软件 | 中出人妻视频一区二区| 观看免费一级毛片| 国产精品99久久久久久久久| 两个人的视频大全免费| www日本黄色视频网| 国产精品久久久久久人妻精品电影| 午夜福利成人在线免费观看| 黑人巨大精品欧美一区二区mp4| 黄片小视频在线播放| 嫩草影院入口| 精品国产乱子伦一区二区三区| 老熟妇仑乱视频hdxx| 欧美三级亚洲精品| 99国产极品粉嫩在线观看| 观看美女的网站| 国产v大片淫在线免费观看| 欧美日韩精品网址| 国产成人福利小说| 成熟少妇高潮喷水视频| 黄色 视频免费看| 欧美日韩中文字幕国产精品一区二区三区| 国产v大片淫在线免费观看| 国内精品一区二区在线观看| 一二三四社区在线视频社区8| 狂野欧美白嫩少妇大欣赏| 国产熟女xx| 在线观看一区二区三区| 欧美色视频一区免费| 成人欧美大片| 日韩成人在线观看一区二区三区| 嫁个100分男人电影在线观看| 日韩大尺度精品在线看网址| 亚洲乱码一区二区免费版| а√天堂www在线а√下载| 日韩欧美在线二视频| 夜夜看夜夜爽夜夜摸| 免费高清视频大片| 成人三级做爰电影| 三级国产精品欧美在线观看 | 欧美日韩瑟瑟在线播放| 国产高清视频在线观看网站| av片东京热男人的天堂| 小说图片视频综合网站| 日韩三级视频一区二区三区| 人妻久久中文字幕网| 麻豆成人av在线观看| 中文字幕人妻丝袜一区二区| 亚洲一区高清亚洲精品| 国产一级毛片七仙女欲春2| 欧美一区二区国产精品久久精品| 日本三级黄在线观看| 欧美日韩黄片免| 综合色av麻豆| 亚洲av电影不卡..在线观看| 国产乱人视频| 国产成人精品无人区| 天堂影院成人在线观看| 午夜影院日韩av| 久久亚洲真实| 亚洲午夜理论影院| 久久天堂一区二区三区四区| 青草久久国产| 国产精品永久免费网站| 久久久久免费精品人妻一区二区| 国产视频一区二区在线看| 日韩欧美国产一区二区入口| 亚洲激情在线av| 国产精品女同一区二区软件 | 两人在一起打扑克的视频| 亚洲天堂国产精品一区在线| 两性午夜刺激爽爽歪歪视频在线观看| 免费看a级黄色片| 成在线人永久免费视频| 国产综合懂色| 亚洲成人中文字幕在线播放| 国产精华一区二区三区| 日本熟妇午夜| 国产精品九九99| 欧美丝袜亚洲另类 | 给我免费播放毛片高清在线观看| 不卡av一区二区三区| 国产精品免费一区二区三区在线| 美女 人体艺术 gogo| 日韩国内少妇激情av| 色吧在线观看| 亚洲一区高清亚洲精品| av天堂中文字幕网| 日韩欧美免费精品| 欧美一级a爱片免费观看看| 亚洲精品一区av在线观看| 老鸭窝网址在线观看| 亚洲在线自拍视频| 亚洲成人久久性| 中文字幕人妻丝袜一区二区| 欧美乱妇无乱码| 一本精品99久久精品77| 欧美激情久久久久久爽电影| 国产伦精品一区二区三区视频9 | 欧美日本亚洲视频在线播放| 丰满的人妻完整版| 亚洲欧美一区二区三区黑人| 最新在线观看一区二区三区| 久久热在线av| 无限看片的www在线观看| 97碰自拍视频| 变态另类丝袜制服| 日本一二三区视频观看| 欧美国产日韩亚洲一区| 欧美日韩精品网址| 精品人妻1区二区| 成年女人永久免费观看视频| 精品欧美国产一区二区三| 亚洲第一电影网av| 国产精品98久久久久久宅男小说| 亚洲成人精品中文字幕电影| 国产一区二区三区在线臀色熟女| 亚洲人成电影免费在线| 波多野结衣巨乳人妻| 欧美+亚洲+日韩+国产| АⅤ资源中文在线天堂| 美女cb高潮喷水在线观看 | 久久久久久人人人人人| 亚洲av美国av| a级毛片在线看网站| 亚洲第一欧美日韩一区二区三区| 国产伦在线观看视频一区| 男人舔奶头视频| 国产亚洲欧美在线一区二区| 国产成人aa在线观看| 国产在线精品亚洲第一网站| 国产精品亚洲美女久久久| av中文乱码字幕在线| 嫩草影院精品99| 免费在线观看亚洲国产| 无限看片的www在线观看| 久久中文看片网| 在线看三级毛片| 一区二区三区激情视频| 欧美激情久久久久久爽电影| 国产精品日韩av在线免费观看| 欧美日韩亚洲国产一区二区在线观看| 欧美日本亚洲视频在线播放| 免费观看的影片在线观看| 亚洲欧美日韩东京热| 国产av不卡久久| 老司机福利观看| 91字幕亚洲| 久久天躁狠狠躁夜夜2o2o| 99国产精品99久久久久| 国产高清视频在线观看网站| 伦理电影免费视频| 亚洲片人在线观看| 欧美中文日本在线观看视频| 又粗又爽又猛毛片免费看| 啪啪无遮挡十八禁网站| 日韩国内少妇激情av| 久久香蕉国产精品| 亚洲国产精品久久男人天堂| 中文字幕人成人乱码亚洲影| 亚洲欧美激情综合另类| 亚洲 国产 在线| 欧美成人一区二区免费高清观看 | 久久精品综合一区二区三区| 99久久国产精品久久久| 搡老熟女国产l中国老女人| 亚洲自拍偷在线| 免费搜索国产男女视频| 99久久成人亚洲精品观看| 国语自产精品视频在线第100页| 香蕉av资源在线| 久久这里只有精品19| 国产精品99久久99久久久不卡| 琪琪午夜伦伦电影理论片6080| 1024手机看黄色片| 亚洲专区字幕在线| 日韩欧美一区二区三区在线观看| 青草久久国产| www.熟女人妻精品国产| 每晚都被弄得嗷嗷叫到高潮| 国产精品自产拍在线观看55亚洲| 日本撒尿小便嘘嘘汇集6| netflix在线观看网站| 成人av一区二区三区在线看| 亚洲国产欧洲综合997久久,| 香蕉国产在线看| 精品国内亚洲2022精品成人| 老熟妇仑乱视频hdxx| 最近视频中文字幕2019在线8| 国产亚洲欧美98| 亚洲午夜精品一区,二区,三区| 美女午夜性视频免费| 亚洲国产精品成人综合色| 亚洲男人的天堂狠狠| 99视频精品全部免费 在线 | svipshipincom国产片| 亚洲成人免费电影在线观看| 老鸭窝网址在线观看| 国产免费男女视频| av在线天堂中文字幕| 啦啦啦韩国在线观看视频| 欧美在线黄色| 精品久久久久久久末码| 久久久久精品国产欧美久久久| 身体一侧抽搐| 老汉色av国产亚洲站长工具| 精品一区二区三区视频在线 | 国内精品一区二区在线观看| 国产精品久久久久久精品电影| 精品欧美国产一区二区三| 中文字幕高清在线视频| 一级a爱片免费观看的视频| 一边摸一边抽搐一进一小说| 脱女人内裤的视频| 人人妻,人人澡人人爽秒播| 91在线精品国自产拍蜜月 | 免费一级毛片在线播放高清视频| 精品久久久久久,| 桃红色精品国产亚洲av| 亚洲中文日韩欧美视频| 国内揄拍国产精品人妻在线| 后天国语完整版免费观看| av天堂中文字幕网| 精品久久久久久久末码| 成年版毛片免费区| 51午夜福利影视在线观看| 国产av麻豆久久久久久久| 18禁国产床啪视频网站| www国产在线视频色| 在线观看66精品国产| 亚洲熟妇中文字幕五十中出| 国内精品久久久久久久电影| 一本综合久久免费| 国产主播在线观看一区二区| 精品欧美国产一区二区三| 一本综合久久免费| 国产91精品成人一区二区三区| 18禁黄网站禁片午夜丰满| www日本在线高清视频| 国产精品,欧美在线| 热99re8久久精品国产| 老熟妇乱子伦视频在线观看| 国产精品一区二区三区四区久久| 亚洲人成伊人成综合网2020| h日本视频在线播放| 欧美性猛交黑人性爽| 熟女少妇亚洲综合色aaa.| av在线蜜桃| 欧美成人性av电影在线观看| 不卡av一区二区三区| 欧美日韩乱码在线| 欧美乱色亚洲激情| 两个人视频免费观看高清| 久久久久免费精品人妻一区二区| 综合色av麻豆| 小蜜桃在线观看免费完整版高清| 国产精品日韩av在线免费观看| 脱女人内裤的视频| 成人特级av手机在线观看| 日日夜夜操网爽| 十八禁网站免费在线| 中文在线观看免费www的网站| 久久99热这里只有精品18| 国产久久久一区二区三区| 男人舔女人下体高潮全视频| 国产激情久久老熟女| 一区福利在线观看| 午夜成年电影在线免费观看| 免费av毛片视频| 色尼玛亚洲综合影院| 国产不卡一卡二| 精品久久久久久成人av| 国产精品av视频在线免费观看| 午夜福利成人在线免费观看| 国产免费av片在线观看野外av| 亚洲精品乱码久久久v下载方式 | 黄片大片在线免费观看| 久久香蕉精品热| 18禁裸乳无遮挡免费网站照片| 变态另类成人亚洲欧美熟女| 桃红色精品国产亚洲av| 免费在线观看影片大全网站| 日韩有码中文字幕| 婷婷精品国产亚洲av在线| 久久这里只有精品19| 久久欧美精品欧美久久欧美| e午夜精品久久久久久久| 最好的美女福利视频网| 免费看日本二区| 巨乳人妻的诱惑在线观看| 精品日产1卡2卡| 国产精品香港三级国产av潘金莲| 亚洲精品乱码久久久v下载方式 | 国产亚洲精品久久久com| 99视频精品全部免费 在线 | 久久久国产欧美日韩av| 亚洲国产看品久久| 黄色片一级片一级黄色片| 欧美一区二区精品小视频在线| 久久久国产成人免费| 亚洲成人久久性| 熟女人妻精品中文字幕| 日本与韩国留学比较| 久久久国产成人精品二区| 丁香欧美五月| 日本在线视频免费播放| 岛国视频午夜一区免费看| 精品国产乱子伦一区二区三区| 国产私拍福利视频在线观看| 啦啦啦观看免费观看视频高清| 日本精品一区二区三区蜜桃| 国产激情欧美一区二区| av在线天堂中文字幕| 又黄又粗又硬又大视频| 日本 欧美在线| 亚洲午夜理论影院| 亚洲熟妇熟女久久| 丁香六月欧美| 精品久久久久久久毛片微露脸| 最近最新中文字幕大全电影3| 巨乳人妻的诱惑在线观看| 美女扒开内裤让男人捅视频| 精品国产美女av久久久久小说| 国产综合懂色| 麻豆国产97在线/欧美| 久久久久久久久中文| 免费看美女性在线毛片视频| 欧美日韩瑟瑟在线播放| 午夜福利在线观看吧| 欧美激情久久久久久爽电影| 久久久久久国产a免费观看| 中文字幕熟女人妻在线| 国产v大片淫在线免费观看| 欧美三级亚洲精品| 亚洲七黄色美女视频| 国产1区2区3区精品| 婷婷六月久久综合丁香| 日本黄色片子视频| 国产精品99久久99久久久不卡| 90打野战视频偷拍视频| av黄色大香蕉| 日韩欧美精品v在线| 精品熟女少妇八av免费久了| 日韩精品中文字幕看吧| 国产成年人精品一区二区| 欧美极品一区二区三区四区| 午夜福利高清视频| 99riav亚洲国产免费| 国产熟女xx| 亚洲国产欧美人成| 精品国产乱子伦一区二区三区| 婷婷六月久久综合丁香| 中出人妻视频一区二区| 97碰自拍视频| 狂野欧美白嫩少妇大欣赏| 久久人人精品亚洲av| 国产激情久久老熟女| 国产91精品成人一区二区三区| 99精品在免费线老司机午夜| 叶爱在线成人免费视频播放| 婷婷亚洲欧美| 真人一进一出gif抽搐免费| 男人舔女人的私密视频| 99久久综合精品五月天人人| 国产欧美日韩一区二区三| 午夜精品一区二区三区免费看| 成人特级av手机在线观看| 老司机深夜福利视频在线观看| 天天躁日日操中文字幕| 国产一区二区三区视频了| 中文字幕精品亚洲无线码一区| 美女大奶头视频| 久久久久精品国产欧美久久久| 亚洲av成人av| 一个人看视频在线观看www免费 | 俄罗斯特黄特色一大片| 国产精品98久久久久久宅男小说| 国产欧美日韩一区二区精品| 精品久久久久久,| 色尼玛亚洲综合影院| 国产av不卡久久| 国产午夜精品论理片| 91av网站免费观看| 亚洲国产日韩欧美精品在线观看 | 一区二区三区国产精品乱码| 欧美黑人欧美精品刺激| 夜夜躁狠狠躁天天躁| 成年版毛片免费区| 欧美黑人巨大hd| 亚洲午夜精品一区,二区,三区| 母亲3免费完整高清在线观看| 91在线观看av| 制服丝袜大香蕉在线| 亚洲无线观看免费| 中文字幕熟女人妻在线| 91在线观看av| 又黄又爽又免费观看的视频| а√天堂www在线а√下载| 成年版毛片免费区| 俺也久久电影网| 日本黄色视频三级网站网址| 好男人在线观看高清免费视频| 国产爱豆传媒在线观看| 三级毛片av免费| 亚洲美女黄片视频| www.精华液| 18禁国产床啪视频网站| 久久久久久久久免费视频了| 美女黄网站色视频| av黄色大香蕉| 久久精品国产清高在天天线| 精品日产1卡2卡| 亚洲 国产 在线| aaaaa片日本免费| 国产男靠女视频免费网站| 国产成人精品无人区| 国产精品国产高清国产av| 夜夜爽天天搞| 国产精品99久久99久久久不卡| 国产精品久久久久久人妻精品电影| 又黄又爽又免费观看的视频| 欧美在线一区亚洲| 国产精品99久久99久久久不卡| 天天躁日日操中文字幕| 欧美日韩综合久久久久久 | 色播亚洲综合网| 国产毛片a区久久久久| 香蕉av资源在线| a在线观看视频网站| 99视频精品全部免费 在线 | 日韩欧美在线乱码| 亚洲无线在线观看| 窝窝影院91人妻| 亚洲av日韩精品久久久久久密| 在线国产一区二区在线| 中文字幕熟女人妻在线| 久久久久免费精品人妻一区二区| av在线天堂中文字幕| 又黄又粗又硬又大视频| 制服丝袜大香蕉在线| 超碰成人久久| cao死你这个sao货| 黄色日韩在线| 99riav亚洲国产免费| 一区二区三区激情视频| 一本一本综合久久| 日韩免费av在线播放| 热99re8久久精品国产| 亚洲精品在线观看二区| 狂野欧美激情性xxxx| 一a级毛片在线观看| 国产av一区在线观看免费| 国产91精品成人一区二区三区| 亚洲在线自拍视频| 99久久精品国产亚洲精品| 亚洲真实伦在线观看| 日本黄色片子视频| 一a级毛片在线观看| 国产精品永久免费网站| 国产精品av视频在线免费观看| 亚洲人成电影免费在线| 天堂av国产一区二区熟女人妻| 久久久国产精品麻豆| 免费看光身美女| 最近最新免费中文字幕在线| 亚洲 欧美 日韩 在线 免费| 亚洲欧美日韩高清专用| 国产精品综合久久久久久久免费| 免费在线观看亚洲国产| 亚洲片人在线观看| 亚洲人成网站高清观看| 亚洲无线在线观看| 精品久久久久久久人妻蜜臀av| 香蕉丝袜av| 成年版毛片免费区| 十八禁人妻一区二区| 国产高潮美女av| 精品无人区乱码1区二区| 精品人妻1区二区| 欧美一级毛片孕妇| 亚洲片人在线观看| 欧美大码av| 99在线人妻在线中文字幕| 欧美高清成人免费视频www| 少妇裸体淫交视频免费看高清| 亚洲va日本ⅴa欧美va伊人久久| 最近最新免费中文字幕在线| 久久精品91蜜桃| 亚洲人与动物交配视频| 日本与韩国留学比较| 亚洲avbb在线观看| 久久久久久久久久黄片| 国产探花在线观看一区二区| 最近视频中文字幕2019在线8| 成人高潮视频无遮挡免费网站| 在线观看午夜福利视频| 一进一出抽搐gif免费好疼| 97超级碰碰碰精品色视频在线观看| 美女午夜性视频免费| 国产综合懂色| 欧美性猛交黑人性爽| 国产精品乱码一区二三区的特点| 欧美xxxx黑人xx丫x性爽| 12—13女人毛片做爰片一| 99热6这里只有精品| 日韩 欧美 亚洲 中文字幕| 九色国产91popny在线| 九九热线精品视视频播放| 老熟妇乱子伦视频在线观看| 欧美乱妇无乱码| 2021天堂中文幕一二区在线观| 欧美中文综合在线视频| 九色成人免费人妻av| 国内精品一区二区在线观看| 两性夫妻黄色片| 亚洲美女黄片视频| 黑人欧美特级aaaaaa片| 亚洲av电影在线进入| 国产精品一区二区精品视频观看| 欧美日韩一级在线毛片|